NCT04057079 is a Phase 2 clinical trial of Anugel, Hydrogel sponge in Pain, Postoperative, sponsored by Deep Life Medical Ltd.

Who is sponsoring NCT04057079?

NCT04057079 is sponsored by Deep Life Medical Ltd.

What drugs are being tested in NCT04057079?

Interventions in NCT04057079: Anugel, Hydrogel sponge, Gelatine Sponge.

What condition does NCT04057079 study?

NCT04057079 studies Pain, Postoperative.

Is NCT04057079 still recruiting?

NCT04057079 is currently completed. Last updated 15 August 2019.

Last reviewed 2019-08-15 · How we verify

NCT04057079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparing Anugel With Gelatine Sponges for Pain Management After Hemoroidectomy

Completed Phase 2 Last updated 15 August 2019

What this trial tests

Phase 2 trial testing Anugel, Hydrogel sponge in Pain, Postoperative in 110 participants. Completed in 1 February 2019.

Timeline

4 April 2014

Primary endpoint
9 July 2018

1 February 2019

Quick facts

Lead sponsor	Deep Life Medical Ltd
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	110
Start date	4 April 2014
Primary completion	9 July 2018
Estimated completion	1 February 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Anugel, Hydrogel sponge
Gelatine Sponge

Conditions studied

Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

Deep Life Medical Ltd

Who can join

Eligibility, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-operational pain is the most common problem relating to haemorrhoidectomy. This study aims to evaluate the postoperative effects of Anugel a hydrogel impregnated multi component sponge vs gelatine sponge comparatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04057079 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Deep Life Medical Ltd
Last refreshed: 15 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04057079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing